| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 7 |
460.0 |
beats/min |
15.0 |
39.69 |
tail cuff plethysmography |
0.0 |
acf |
9 |
days |
101375 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
377.0 |
beats/min |
11.0 |
26.94 |
tail cuff plethysmography |
0.0 |
sham acf |
2 |
days |
101379 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
406.0 |
beats/min |
22.0 |
49.19 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101369 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
382.0 |
beats/min |
8.0 |
17.89 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101388 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
460.0 |
beats/min |
9.0 |
22.05 |
tail cuff plethysmography |
0.0 |
acf |
4 |
days |
101368 |
2585 |
| WF/Mol |
heart rate |
controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 7 |
473.0 |
beats/min |
20.0 |
52.92 |
tail cuff plethysmography |
0.0 |
acf |
9 |
days |
101374 |
2585 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
460.0 |
beats/min |
5.0 |
12.25 |
tail cuff plethysmography |
0.0 |
acf |
7 |
days |
101384 |
2585 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
407.0 |
beats/min |
16.0 |
39.19 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101385 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
470.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
0.0 |
acf |
2 |
days |
101378 |
2585 |
| WF/Mol |
heart rate |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
450.0 |
beats/min |
13.0 |
29.07 |
tail cuff plethysmography |
0.0 |
acf |
4 |
days |
101366 |
2585 |
| WF/Mol |
heart rate |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 7 |
443.0 |
beats/min |
6.0 |
15.87 |
tail cuff plethysmography |
0.0 |
acf |
7 |
days |
101370 |
2585 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
482.0 |
beats/min |
12.0 |
29.39 |
tail cuff plethysmography |
0.0 |
acf |
2 |
days |
101376 |
2585 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
410.0 |
beats/min |
8.0 |
19.6 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101381 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 7 |
450.0 |
beats/min |
13.0 |
34.39 |
tail cuff plethysmography |
0.0 |
acf |
7 |
days |
101372 |
2585 |
| WF/Mol |
heart rate |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
402.0 |
beats/min |
31.0 |
69.32 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101371 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
358.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101373 |
2585 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
424.0 |
beats/min |
10.0 |
22.36 |
tail cuff plethysmography |
0.0 |
sham acf |
2 |
days |
101377 |
2585 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 8 |
469.0 |
beats/min |
10.0 |
28.28 |
tail cuff plethysmography |
0.0 |
acf |
4 |
days |
101380 |
2585 |
| WF/Mol |
heart rate |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
366.0 |
beats/min |
14.0 |
31.3 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101367 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
448.0 |
beats/min |
10.0 |
24.49 |
tail cuff plethysmography |
0.0 |
acf |
4 |
days |
101382 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
366.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101383 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
448.0 |
beats/min |
7.0 |
17.15 |
tail cuff plethysmography |
0.0 |
acf |
7 |
days |
101387 |
2585 |